A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart

Hepatology

Volumn 54, Issue 4, 2011, Pages 1282-1292

  Miragoli, Michele ^a   Sheikh Abdul Kadir, Siti H ^a   Sheppard, Mary N ^d   Salvarani, Nicoló ^b   Virta, Matilda ^a   Wells, Sarah ^a   Lab, Max J ^a   Nikolaev, Viacheslav O ^a   Moshkov, Alexey ^a   Hague, William M ^e   Rohr, Stephan ^b   Williamson, Catherine ^c   Gorelik, Julia ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; POTASSIUM; TAUROCHOLIC ACID; URSODEOXYCHOLIC ACID;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; DEPOLARIZATION; DRUG MECHANISM; FETUS; FETUS CELL; FETUS HEART; FETUS HYPOXIA; GAP JUNCTION; HEART; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRAHEPATIC CHOLESTASIS; MATERNAL HEART; MYOFIBROBLAST; NONHUMAN; POTASSIUM CONDUCTANCE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

ADULT; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CELLS, CULTURED; CHOLESTASIS, INTRAHEPATIC; DISEASE MODELS, ANIMAL; FEMALE; FETAL HEART; HEART VENTRICLES; HUMANS; MUSCLE CELLS; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RATS, WISTAR; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 80053328747     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24492     Document Type: Article

References (46)

1. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-2066.
2. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-1405.
3. Al Inizi S, Gupta R, Gale A. Fetal tachyarrhythmia with atrial flutter in obstetric cholestasis. Int J Gynaecol Obstet 2006; 93: 53-54.
4. Shand AW, Dickinson JE, D'Orsogna L. Refractory fetal supraventricular tachycardia and obstetric cholestasis. Fetal Diagn Ther 2008; 24: 277-281.
5. Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95: 1137-1143.
6. Strehlow SL, Pathak B, Goodwin TM, Perez BM, Ebrahimi M, Lee RH. The mechanical PR interval in fetuses of women with intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2010; 203: 455.e1-e5.
7. Sheikh Abdul Kadir SH, Miragoli M, Abu-Hayyeh S, Moshkov AV, Xie Q, Keitel V, et al. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One 2010; 5: e9689.
8. Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Res C Embryo Today 2007; 81: 215-228.
9. Clancy RM, Zheng P, O'Mahony M, Izmirly P, Zavadil J, Gardner L, Buyon JP. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum 2007; 56: 4120-4131.
10. Clement S, Chaponnier C, Gabbiani G. A subpopulation of cardiomyocytes expressing alpha-skeletal actin is identified by a specific polyclonal antibody. Circ Res 1999; 85: e51-e58.
11. Sun Y, Kiani MF, Postlethwaite AE, Weber KT. Infarct scar as living tissue. Basic Res Cardiol 2002; 97: 343-347.
12. Gaudesius G, Miragoli M, Thomas SP, Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 2003; 93: 421-428.
13. Miragoli M, Gaudesius G, Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 2006; 98: 801-810.
14. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 2007; 101: 755-758.
15. Rohr S, Kucera JP. Optical recording system based on a fiber optic image conduit: assessment of microscopic activation patterns in cardiac tissue. Biophys J 1998; 75: 1062-1075.
16. Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010; 327: 1653-1657.
17. Miragoli M, Moshkov A, Novak P, Shevchuk A, Nikolaev VO, El-Hamamsy I, et al. Scanning ion conductance microscopy: a convergent high-resolution technology for multi-parametric analysis of living cardiovascular cells. J R Soc Interface 2011; 8: 913-925.
18. Gorelik J, Shevchuk AI, Diakonov I, de Swiet M, Lab M, Korchev Y, Williamson C. Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes. BJOG 2003; 110: 467-474.
19. Belles B, Hescheler J, Trube G. Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflugers Arch 1987; 409: 582-588.
20. Benamer N, Moha Ou Maati H, Demolombe S, Cantereau A, Delwail A, Bois P, et al. Molecular and functional characterization of a new potassium conductance in mouse ventricular fibroblasts. J Mol Cell Cardiol 2009; 46: 508-517.
21. Rohr S. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm 2009; 6: 848-856.
22. Chilton L, Ohya S, Freed D, George E, Drobic V, Shibukawa Y, et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol 2005; 288: H2931-H2939.
23. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, et al. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res 2003; 92: 264-271.
24. Suurmeijer AJ, Clement S, Francesconi A, Bocchi L, Angelini A, Van Veldhuisen DJ, et al. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol 2003; 199: 387-397.
25. Potta SP, Liang H, Winkler J, Doss MX, Chen S, Wagh V, et al. Isolation and functional characterization of alpha-smooth muscle actin expressing cardiomyocytes from embryonic stem cells. Cell Physiol Biochem 2010; 25: 595-604.
26. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173-182.
27. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006; 113: 1344-1352.
28. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 264-272.
29. Cullen T. Evaluation of fetal arrhythmias. Am Fam Physician 1992; 46: 1745-1749.
30. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004; 25: 234-251.
31. Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis 2007; 2: 26.
32. Kramer DC, Fleischer FS, Marx GF. Fetal bradycardia resulting from maternal hypoglycemia. A report of two cases. J Reprod Med 1995; 40: 394-396.
33. Van Gaever C, Defoort P, Dhont M. Delayed structural development in an acardiac fetus: an echographic observation. Fetal Diagn Ther 2008; 23: 100-104.
34. Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 2009; 5: 139-148.
35. Rohr S, Fluckiger-Labrada R, Kucera JP. Photolithographically defined deposition of attachment factors as a versatile method for patterning the growth of different cell types in culture. Pflugers Arch 2003; 446: 125-132.
36. Gorelik J, Harding SE, Shevchuk AI, Koralage D, Lab M, de Swiet M, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) 2002; 103: 191-200.
37. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-2066.
38. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008; 47: 544-551.
39. Kamkin A, Kiseleva I, Lozinsky I, Scholz H. Electrical interaction of mechanosensitive fibroblasts and myocytes in the heart. Basic Res Cardiol 2005; 100: 337-345.
40. Kamkin A, Kiseleva I, Wagner KD, Lozinsky I, Gunther J, Scholz H. Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation. Pflugers Arch 2003; 446: 169-174.
41. Chilton L, Giles WR, Smith GL. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 2007; 583: 225-236.
42. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997; 27: 1022-1028.
43. Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894-901.
44. Gurung V, Williamson C, Chappell L, Chambers J, Briley A, Broughton Pipkin F, Thornton J. Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis. BMC Pregnancy Childbirth 2009; 9: 19.
45. Camelliti P, Devlin GP, Matthews KG, Kohl P, Green CR. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res 2004; 62: 415-425.
46. Sui GP, Rothery S, Dupont E, Fry CH, Severs NJ. Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 2002; 90: 118-129.